Pfizer · 18 hours ago
Quality Control Analyst I
United States - Washington – Bothell
Full-time
Onsite
New Grad, Entry Level
$24.09/hr - $40.15/hr
0+ years expPfizer is dedicated to the quality and delivery of safe and effective products to patients. The Quality Control Analyst I will perform lab support activities and participate in routine and non-routine testing in a GMP testing environment, ensuring compliance with quality standards.
BiotechnologyHealth CareMedicalPharmaceuticalPrecision Medicine
No H1B
Responsibilities
Applying the principles of good manufacturing practices (GMP) on a daily basis
Performing maintenance of QC lab equipment, procedures and systems
Performing QC sample testing
Creating and revising standard operating procedures (SOP’s) and other documents as needed
Identifying and participating in continuous improvement projects
Maintain training to current standards and procedures on all assigned curriculums
Fully comply with company health and safety procedures and practices
Preparing solutions used for QC Testing
May require lifting/moving heavy objects
Qualification
Required
Associates degree in a relevant field or a Bachelor's degree in a relevant field and 0-2 years of experience working in a GMP laboratory
Broad experience with Microsoft Office products
Highly organized with an attention to detail
Knowledge of biological and/or chemical handling
Benefits
401(k) plan with Pfizer Matching Contributions
An additional Pfizer Retirement Savings Contribution
Paid vacation
Holiday and personal days
Paid caregiver/parental and medical leave
Health benefits to include medical, prescription drug, dental and vision coverage
Company
Pfizer
Pfizer is a biopharmaceutical company that discovers, develops, and delivers medicines and vaccines.
10001+ employees
Funding
Current Stage
Public CompanyTotal Funding
$38BKey Investors
Starboard Value
2025-11-21Post Ipo Debt· $6B
2024-10-07Post Ipo Equity· $1B
2023-05-16Post Ipo Debt· $31B
Leadership Team
Albert Bourla
Chief Executive Officer
Ian Read
Chief Executive Officer
Recent News
2026-01-25
Pharma Letter
2026-01-25
Company data provided by crunchbase